Biotechnology stocks have been the story thus far this week as investors finally rotated some money back into this group of stocks. While for Clubhouse members I have been pounding the ‘buy’ signal since June 1st in this space, the question now is whether one can still buy these stocks at current levels and how far they can rally from here.
